SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+5.97%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.65B
AUM Growth
-$492M
(-23%)
Cap. Flow
-$582M
Cap. Flow
% of AUM
-35.28%
Top 10 Holdings %
Top 10 Hldgs %
88.92%
Holding
110
New
15
Increased
16
Reduced
49
Closed
20
Top Buys
| 1 |
SBAR
Simplify Barrier Income ETF
SBAR
|
$28.8M |
| 2 |
XV
Simplify Target 15 Distribution ETF
XV
|
$26.6M |
| 3 |
National Vision
EYE
|
$6.47M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$6.2M |
| 5 |
GeneDx Holdings
WGS
|
$5.23M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$488M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$55.9M |
| 3 |
Simplify High Yield ETF
CDX
|
$29.8M |
| 4 |
Simplify US Equity PLUS Upside Convexity ETF
SPUC
|
$18.8M |
| 5 |
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
|
$12.5M |
Sector Composition
| 1 | Healthcare | 7.83% |
| 2 | Energy | 1.5% |
| 3 | Consumer Discretionary | 0.88% |
| 4 | Industrials | 0.66% |
| 5 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cardinal Health
CAH
$36B
| $3.89M | 0.2% |
23,229
-27,983
| -55% | -$4.69M |
|
27
Danaher
DHR
$143B
| $3.6M | 0.18% |
18,245
-23,599
| -56% | -$4.66M |
|
28
Fluor
FLR
$6.93B
| $3.5M | 0.18% |
+68,174
| New | +$3.5M |
|
29
AbbVie
ABBV
$374B
| $3.41M | 0.17% |
18,384
-2,018
| -10% | -$375K |
|
30
CVS Health
CVS
$93B
| $3.24M | 0.16% |
46,966
+37,861
| +416% | +$2.61M |
|
31
Abeona Therapeutics
ABEO
$356M
| $3.17M | 0.16% |
558,584
+150,000
| +37% | +$852K |
|
32
Pacira BioSciences
PCRX
$1.22B
| $2.89M | 0.15% |
120,843
-13,199
| -10% | -$315K |
|
33
Achieve Life Sciences
ACHV
$146M
| $2.68M | 0.13% |
1,184,512
+966,667
| +444% | +$2.18M |
|
34
Cencora
COR
$57.2B
| $2.62M | 0.13% |
+8,753
| New | +$2.62M |
|
35
ResMed
RMD
$39.4B
| $2.58M | 0.13% |
10,005
-1,096
| -10% | -$283K |
|
|
LITL
36
Simplify Piper Sandler US Small-Cap PLUS Income ETF
LITL
$5.69M
| $2.53M | 0.13% |
+91,464
| New | +$2.53M |
|
37
AstraZeneca
AZN
$255B
| $2.27M | 0.11% |
32,451
-3,539
| -10% | -$247K |
|
38
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.94M | 0.1% |
3,697
+939
| +34% | +$493K |
|
39
Milestone Pharmaceuticals
MIST
$151M
| $1.92M | 0.1% |
990,000
+140,000
| +16% | +$272K |
|
40
GE HealthCare
GEHC
$33B
| $1.84M | 0.09% |
+24,776
| New | +$1.84M |
|
41
DexCom
DXCM
$30.9B
| $1.8M | 0.09% |
20,650
+1,841
| +10% | +$161K |
|
42
Alignment Healthcare
ALHC
$3.23B
| $1.68M | 0.08% |
120,321
-13,145
| -10% | -$184K |
|
43
Rithm Capital
RITM
$6.55B
| $1.6M | 0.08% |
142,085
-48,695
| -26% | -$550K |
|
44
Insmed
INSM
$30.3B
| $1.56M | 0.08% |
15,536
-5,094
| -25% | -$513K |
|
45
Johnson & Johnson
JNJ
$429B
| $1.53M | 0.08% |
10,005
-32,212
| -76% | -$4.92M |
|
46
TScan Therapeutics
TCRX
$106M
| $1.52M | 0.08% |
1,046,916
| – | – |
|
47
Quest Diagnostics
DGX
$20.1B
| $1.47M | 0.07% |
8,161
-12,510
| -61% | -$2.25M |
|
48
Delcath Systems
DCTH
$381M
| $1.45M | 0.07% |
106,629
-10,371
| -9% | -$141K |
|
49
Applied Therapeutics
APLT
$73.7M
| $1.4M | 0.07% |
4,487,505
| – | – |
|
50
Revvity
RVTY
$9.68B
| $1.4M | 0.07% |
14,426
-1,577
| -10% | -$153K |
|